PONIARD PHARMACEUTICALS, INC. Inactive Instrument
Poniard Pharmaceuticals, Inc. Share Price Other OTC
Equities
PARD
US7324494001
Pharmaceuticals
Days
Hours
Minutes
Seconds
-40%
on all our subscriptions*
Exceptional extension!
Take advantage of the offer
* See conditions on site
| Sales 2009 | - | Sales 2010 | - | Capitalization | 25.13M 1.98B |
|---|---|---|---|---|---|
| Net income 2009 | -45M -3.55B | Net income 2010 | -30M -2.36B | EV / Sales 2009 | - |
| Net cash position 2009 | 23.12M 1.82B | Net cash position 2010 | 2.76M 217M | EV / Sales 2010 | - |
| P/E ratio 2009 |
-1.4
x | P/E ratio 2010 |
-0.79
x | Employees | - |
| Yield 2009 * |
-
| Yield 2010 |
-
| Free-Float | 2.5% |
More Fundamentals
* Assessed data
Poniard Pharmaceuticals, Inc. is a biopharmaceutical company. The Company focuses on the development and commercialization of oncology products to impact the lives of people with cancer. It develops picoplatin, a platinum-based chemotherapeutic agent that is in clinical development for multiple cancer indications, treatment combinations and by two routes of administration. The Company has offices in San Francisco, California; and Seattle, Washington in United States.
Sector
Pharmaceuticals
| 1st Jan change | Capi. | |
|---|---|---|
| +2.52% | 92.1B | |
| -3.16% | 37.92B | |
| -12.49% | 32.97B | |
| +74.97% | 27.92B | |
| -11.82% | 16.14B | |
| -0.16% | 14.1B | |
| -11.18% | 11.66B | |
| +171.57% | 10.29B | |
| -50.45% | 9.99B |
